(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of GPT2 mRNA] CTD PMID:31150632 1,2-dimethylhydrazine decreases expression ISO RGD:1313503 6480464 1, 2-Dimethylhydrazine results in decreased expression of GPT2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1313503 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GPT2 mRNA CTD PMID:22206623 1-nitropyrene increases expression ISO RGD:1313502 6480464 1-nitropyrene results in increased expression of GPT2 mRNA CTD PMID:19041380 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of GPT2 mRNA CTD PMID:20068009 17beta-estradiol decreases expression ISO RGD:1313503 6480464 Estradiol results in decreased expression of GPT2 mRNA CTD PMID:19484750 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1313503 6480464 Tetrachlorodibenzodioxin results in decreased expression of GPT2 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1313503 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GPT2 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1313502 6480464 Tetrachlorodibenzodioxin results in decreased expression of GPT2 mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of GPT2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of GPT2 mRNA CTD PMID:21215274 , PMID:32109520 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-diaminobutyric acid multiple interactions ISO RGD:1313502 6480464 [beta-N-methylamino-L-alanine co-treated with 2, 4-diaminobutyric acid] results in increased expression of GPT2 mRNA CTD PMID:28634653 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:1313502 6480464 2 more ... CTD PMID:26705709 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of GPT2 mRNA CTD PMID:21346803 2-amino-14,16-dimethyloctadecan-3-ol decreases expression ISO RGD:1313502 6480464 2-amino-14, 16-dimethyloctadecan-3-ol results in decreased expression of GPT2 protein CTD PMID:32044396 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:1313503 6480464 3 more ... CTD PMID:19467301 4,4'-diaminodiphenylmethane increases expression ISO RGD:1313503 6480464 4, 4'-diaminodiphenylmethane results in increased expression of GPT2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol decreases expression ISO RGD:1313503 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of GPT2 mRNA CTD PMID:33297965 4,4'-sulfonyldiphenol increases methylation ISO RGD:1313502 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of GPT2 gene CTD PMID:31601247 4-hydroxyphenyl retinamide decreases expression ISO RGD:1313503 6480464 Fenretinide results in decreased expression of GPT2 mRNA CTD PMID:28973697 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of GPT2 mRNA CTD PMID:31881176 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of GPT2 mRNA CTD PMID:28959563 acrylamide increases expression ISO RGD:1313502 6480464 Acrylamide results in increased expression of GPT2 mRNA CTD PMID:32763439 aflatoxin B1 multiple interactions EXP 6480464 [sulforaphane co-treated with Aflatoxin B1] affects the expression of GPT2 mRNA CTD PMID:25450479 aflatoxin B1 affects methylation ISO RGD:1313502 6480464 Aflatoxin B1 affects the methylation of GPT2 intron CTD PMID:30157460 aflatoxin B1 decreases methylation ISO RGD:1313502 6480464 Aflatoxin B1 results in decreased methylation of GPT2 gene CTD PMID:27153756 Aflatoxin B2 alpha increases methylation ISO RGD:1313502 6480464 aflatoxin B2 results in increased methylation of GPT2 intron CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO RGD:1313502 6480464 Tretinoin results in decreased expression of GPT2 mRNA CTD PMID:33167477 amiodarone increases expression ISO RGD:1313503 6480464 Amiodarone results in increased expression of GPT2 mRNA CTD PMID:24489787 aristolochic acid decreases expression ISO RGD:1313502 6480464 aristolochic acid I results in decreased expression of GPT2 mRNA CTD PMID:33212167 arsenite(3-) affects expression ISO RGD:1313502 6480464 arsenite affects the expression of GPT2 mRNA CTD PMID:22959463 arsenite(3-) multiple interactions ISO RGD:1313502 6480464 arsenite inhibits the reaction [G3BP1 protein binds to GPT2 mRNA] CTD PMID:32406909 arsenous acid increases expression ISO RGD:1313502 6480464 Arsenic Trioxide results in increased expression of GPT2 mRNA CTD PMID:24356939 atrazine decreases expression ISO RGD:1313502 6480464 Atrazine results in decreased expression of GPT2 mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO RGD:1313503 6480464 Benzo(a)pyrene results in decreased expression of GPT2 mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO RGD:1313502 6480464 Benzo(a)pyrene affects the methylation of GPT2 intron CTD PMID:30157460 benzo[a]pyrene decreases methylation ISO RGD:1313502 6480464 Benzo(a)pyrene results in decreased methylation of GPT2 3' UTR, Benzo(a)pyrene results in decreased methylation of GPT2 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1313502 6480464 Benzo(a)pyrene metabolite results in decreased expression of GPT2 mRNA more ... CTD PMID:20064835 more ... benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of GPT2 mRNA CTD PMID:21839799 benzo[e]pyrene affects methylation ISO RGD:1313502 6480464 benzo(e)pyrene affects the methylation of GPT2 intron CTD PMID:30157460 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GPT2 mRNA CTD PMID:25181051 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of GPT2 mRNA CTD PMID:30903817 butan-1-ol multiple interactions ISO RGD:1313502 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GPT2 mRNA CTD PMID:29432896 cadmium atom multiple interactions ISO RGD:1313502 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GPT2 mRNA CTD PMID:35301059 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of GPT2 mRNA CTD PMID:33453195 cadmium dichloride multiple interactions ISO RGD:1313502 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GPT2 mRNA CTD PMID:35301059 calcitriol increases expression ISO RGD:1313502 6480464 Calcitriol results in increased expression of GPT2 mRNA CTD PMID:26485663 cannabidiol increases expression ISO RGD:1313503 6480464 Cannabidiol results in increased expression of GPT2 mRNA CTD PMID:21542829 carbamazepine affects expression ISO RGD:1313502 6480464 Carbamazepine affects the expression of GPT2 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1313503 6480464 Nanotubes more ... CTD PMID:25620056 CGP 52608 multiple interactions ISO RGD:1313502 6480464 CGP 52608 promotes the reaction [RORA protein binds to GPT2 gene] CTD PMID:28238834 chloropicrin affects expression ISO RGD:1313502 6480464 chloropicrin affects the expression of GPT2 mRNA CTD PMID:26352163 chloroprene increases expression ISO RGD:1313503 6480464 Chloroprene results in increased expression of GPT2 mRNA CTD PMID:23125180 ciguatoxin CTX1B affects expression ISO RGD:1313503 6480464 Ciguatoxins affects the expression of GPT2 mRNA CTD PMID:18353800 cisplatin increases expression ISO RGD:1313502 6480464 Cisplatin results in increased expression of GPT2 mRNA CTD PMID:27594783 clofibrate decreases expression ISO RGD:1313503 6480464 Clofibrate results in decreased expression of GPT2 mRNA CTD PMID:23811191 cobalt atom multiple interactions ISO RGD:1313502 6480464 [tungsten carbide co-treated with Cobalt] results in increased expression of GPT2 mRNA CTD PMID:23052192 cobalt dichloride increases expression ISO RGD:1313502 6480464 cobaltous chloride results in increased expression of GPT2 mRNA CTD PMID:24356939 copper atom multiple interactions ISO RGD:1313502 6480464 [Chelating Agents binds to Copper] which results in increased expression of GPT2 mRNA, [Disulfiram binds to Copper] which results in increased expression of GPT2 mRNA CTD PMID:24690739 , PMID:30911355 copper(0) multiple interactions ISO RGD:1313502 6480464 [Chelating Agents binds to Copper] which results in increased expression of GPT2 mRNA, [Disulfiram binds to Copper] which results in increased expression of GPT2 mRNA CTD PMID:24690739 , PMID:30911355 copper(II) sulfate affects expression ISO RGD:1313502 6480464 Copper Sulfate affects the expression of GPT2 mRNA CTD PMID:19549813 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of GPT2 mRNA CTD PMID:26577399 cyclophosphamide decreases expression ISO RGD:1313502 6480464 Cyclophosphamide metabolite results in decreased expression of GPT2 mRNA CTD PMID:24356939 cyclosporin A increases expression ISO RGD:1313502 6480464 Cyclosporine results in increased expression of GPT2 mRNA CTD PMID:20106945 , PMID:27989131 cyclosporin A decreases expression ISO RGD:1313503 6480464 Cyclosporine results in decreased expression of GPT2 mRNA CTD PMID:19770486 , PMID:23308384 cyclosporin A increases expression ISO RGD:1313503 6480464 Cyclosporine results in increased expression of GPT2 mRNA CTD PMID:25224403 dextran sulfate decreases expression ISO RGD:1313503 6480464 Dextran Sulfate results in decreased expression of GPT2 mRNA CTD PMID:35093514 diarsenic trioxide increases expression ISO RGD:1313502 6480464 Arsenic Trioxide results in increased expression of GPT2 mRNA CTD PMID:24356939 diazinon increases expression ISO RGD:1313502 6480464 Diazinon results in increased expression of GPT2 mRNA CTD PMID:24356939 diazinon increases methylation ISO RGD:1313502 6480464 Diazinon results in increased methylation of GPT2 gene CTD PMID:22964155 diclofenac decreases expression ISO RGD:1313503 6480464 Diclofenac results in decreased expression of GPT2 mRNA CTD PMID:35537566 disulfiram multiple interactions ISO RGD:1313502 6480464 [Disulfiram binds to Copper] which results in increased expression of GPT2 mRNA CTD PMID:24690739 doxorubicin decreases expression ISO RGD:1313502 6480464 Doxorubicin results in decreased expression of GPT2 mRNA CTD PMID:29803840 epoxiconazole decreases expression ISO RGD:1313503 6480464 epoxiconazole results in decreased expression of GPT2 mRNA CTD PMID:35436446 ethanol multiple interactions ISO RGD:1313502 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GPT2 mRNA CTD PMID:29432896 ethanol affects expression ISO RGD:1313503 6480464 Ethanol affects the expression of GPT2 mRNA CTD PMID:30319688 folic acid multiple interactions ISO RGD:1313503 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GPT2 mRNA CTD PMID:22206623 folic acid decreases expression ISO RGD:1313503 6480464 Folic Acid results in decreased expression of GPT2 mRNA CTD PMID:25629700 gamma-hexachlorocyclohexane increases expression ISO RGD:1313502 6480464 Hexachlorocyclohexane results in increased expression of GPT2 mRNA CTD PMID:24356939 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of GPT2 mRNA CTD PMID:24136188 hydrogen peroxide affects expression ISO RGD:1313502 6480464 Hydrogen Peroxide affects the expression of GPT2 mRNA CTD PMID:20044591 hydrogen peroxide increases expression ISO RGD:1313502 6480464 Hydrogen Peroxide results in increased expression of GPT2 mRNA CTD PMID:18951874 lipopolysaccharide multiple interactions ISO RGD:1313502 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of GPT2 mRNA CTD PMID:35811015 menadione affects expression ISO RGD:1313502 6480464 Vitamin K 3 affects the expression of GPT2 mRNA CTD PMID:20044591 methapyrilene affects methylation ISO RGD:1313502 6480464 Methapyrilene affects the methylation of GPT2 intron CTD PMID:30157460 methotrexate affects expression ISO RGD:1313503 6480464 Methotrexate affects the expression of GPT2 mRNA CTD PMID:18502557 methylmercury chloride increases expression ISO RGD:1313502 6480464 methylmercuric chloride results in increased expression of GPT2 mRNA CTD PMID:28001369 motexafin gadolinium increases expression ISO RGD:1313502 6480464 motexafin gadolinium results in increased expression of GPT2 mRNA CTD PMID:16357179 N-methyl-4-phenylpyridinium increases expression ISO RGD:1313503 6480464 1-Methyl-4-phenylpyridinium results in increased expression of GPT2 mRNA CTD PMID:22776087 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of GPT2 mRNA CTD PMID:28801915 N-methyl-4-phenylpyridinium increases expression ISO RGD:1313502 6480464 1-Methyl-4-phenylpyridinium results in increased expression of GPT2 mRNA CTD PMID:24810058 neomycin decreases expression ISO RGD:1313503 6480464 Neomycin results in decreased expression of GPT2 mRNA CTD PMID:30626089 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of GPT2 mRNA CTD PMID:24136188 ochratoxin A decreases expression ISO RGD:1313502 6480464 ochratoxin A metabolite results in decreased expression of GPT2 mRNA CTD PMID:24356939 oxycodone increases expression EXP 6480464 Oxycodone results in increased expression of GPT2 mRNA CTD PMID:23439660 paracetamol affects expression ISO RGD:1313503 6480464 Acetaminophen affects the expression of GPT2 mRNA CTD PMID:17562736 paracetamol increases activity EXP 6480464 Acetaminophen results in increased activity of GPT2 protein CTD PMID:19085960 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of GPT2 protein CTD PMID:19085960 perfluorononanoic acid increases expression ISO RGD:1313502 6480464 perfluoro-n-nonanoic acid results in increased expression of GPT2 mRNA CTD PMID:32588087 perfluorooctanoic acid increases expression ISO RGD:1313502 6480464 perfluorooctanoic acid results in increased expression of GPT2 protein CTD PMID:26879310 phenobarbital increases expression ISO RGD:1313503 6480464 Phenobarbital results in increased expression of GPT2 mRNA CTD PMID:19270015 pirinixic acid multiple interactions ISO RGD:1313502 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of GPT2 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO RGD:1313503 6480464 pirinixic acid results in decreased expression of GPT2 mRNA CTD PMID:23811191 pirinixic acid increases expression ISO RGD:1313503 6480464 pirinixic acid results in increased expression of GPT2 mRNA CTD PMID:18445702 potassium chromate increases expression ISO RGD:1313502 6480464 potassium chromate(VI) results in increased expression of GPT2 mRNA CTD PMID:22714537 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1313503 6480464 Pregnenolone Carbonitrile results in increased expression of GPT2 mRNA CTD PMID:27413110 propiconazole decreases expression ISO RGD:1313503 6480464 propiconazole results in decreased expression of GPT2 mRNA CTD PMID:21278054 prothioconazole increases expression ISO RGD:1313502 6480464 prothioconazole results in increased expression of GPT2 mRNA CTD PMID:35048155 quercetin decreases expression ISO RGD:1313502 6480464 Quercetin results in decreased expression of GPT2 mRNA CTD PMID:21632981 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO RGD:1313502 6480464 S-(1, 2-dichlorovinyl)cysteine results in increased expression of GPT2 mRNA CTD PMID:33725128 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1313502 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of GPT2 mRNA CTD PMID:35811015 sulforaphane multiple interactions EXP 6480464 [sulforaphane co-treated with Aflatoxin B1] affects the expression of GPT2 mRNA CTD PMID:25450479 sunitinib increases expression ISO RGD:1313502 6480464 Sunitinib results in increased expression of GPT2 mRNA CTD PMID:31533062 temozolomide increases expression ISO RGD:1313502 6480464 Temozolomide results in increased expression of GPT2 mRNA CTD PMID:31758290 tetrachloromethane increases activity ISO RGD:1313503 6480464 Carbon Tetrachloride results in increased activity of GPT2 protein CTD PMID:19085960 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of GPT2 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of GPT2 mRNA] CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:1313503 6480464 Carbon Tetrachloride results in increased expression of GPT2 mRNA, Carbon Tetrachloride results in increased expression of GPT2 protein CTD PMID:19085960 more ... tetracycline decreases expression ISO RGD:1313503 6480464 Tetracycline results in decreased expression of GPT2 mRNA CTD PMID:24489787 thapsigargin increases expression ISO RGD:1313502 6480464 Thapsigargin results in increased expression of GPT2 mRNA CTD PMID:22378314 , PMID:29453283 titanium dioxide decreases expression ISO RGD:1313503 6480464 titanium dioxide results in decreased expression of GPT2 mRNA CTD PMID:23557971 tributylstannane decreases expression EXP 6480464 tributyltin results in decreased expression of GPT2 mRNA CTD PMID:31129395 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of GPT2 gene CTD PMID:27618143 trovafloxacin decreases expression ISO RGD:1313503 6480464 trovafloxacin results in decreased expression of GPT2 mRNA CTD PMID:35537566 Tungsten carbide multiple interactions ISO RGD:1313502 6480464 [tungsten carbide co-treated with Cobalt] results in increased expression of GPT2 mRNA CTD PMID:23052192 tunicamycin increases expression ISO RGD:1313502 6480464 Tunicamycin results in increased expression of GPT2 mRNA CTD PMID:22378314 , PMID:29453283 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of GPT2 mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:1313503 6480464 Valproic Acid affects the expression of GPT2 mRNA CTD PMID:17292431 valproic acid decreases methylation ISO RGD:1313502 6480464 Valproic Acid results in decreased methylation of GPT2 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:1313502 6480464 Valproic Acid results in increased expression of GPT2 mRNA CTD PMID:29154799 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of GPT2 mRNA CTD PMID:19015723 zinc acetate increases expression ISO RGD:1313502 6480464 Zinc Acetate results in increased expression of GPT2 mRNA CTD PMID:16357179
